Join the Multiple Sclerosis group to help and get support from people like you.
Multiple Sclerosis News
Related terms: MS
Autoimmune Diseases Linked to Digestive System Cancers
FRIDAY, Aug. 15, 2025 – Autoimmune diseases are associated with certain digestive system cancers, according to a review published in the September issue of eClinicalMedicine. Julia Reizner, from the...
Broader Formulary Coverage Linked to Lower Odds of MS Relapse
FRIDAY, Aug. 8, 2025 – Broader formulary coverage is associated with lower odds of multiple sclerosis (MS) relapse among Medicare beneficiaries, according to a study published online Aug. 1 in JAMA...
Increase Seen in Physician Visits ~15 Years Before MS Onset
THURSDAY, Aug. 7, 2025 – Health care use is increased years before onset of multiple sclerosis (MS), according to a study published online Aug. 1 in JAMA Network Open. Marta Ruiz-Algueró, M.D., ...
When Insurers Restrict MS Drug Coverage, Relapses Rise
TUESDAY, Aug. 5, 2025 — Multiple sclerosis (MS) patients might have a higher risk of relapse if their health insurance is stingy with prescriptions, a new study reports. Patients with insurance plans ...
MS May Begin Years Earlier Than Thought
MONDAY, Aug. 4, 2025 — People with multiple sclerosis (MS) begin experiencing new health issues up to 15 years before the classic signs of the illness appear, Canadian research shows. “MS can be dif...
Women Less Likely to Get Certain MS Meds Than Men
THURSDAY, July 31, 2025 — Women are less likely than men to receive multiple sclerosis (MS) meds that could help them manage the disease and delay disability, a new report finds. It could be that s...
Women With MS Less Likely Than Men to Receive Disease-Modifying Therapies
THURSDAY, July 31, 2025 – Women with multiple sclerosis (MS) are less likely to receive disease-modifying therapies (DMTs) than men, according to a study published online July 30 in Neurology....
Blood Test Might Predict MS Relapse
TUESDAY, June 24, 2025 — A blood test might predict when multiple sclerosis patients are about to suffer a relapse in their symptoms, a new study says. Blood levels of a protein called neurofilament l...
Greater Epigenetic Age Seen in Patients With Pediatric-Onset MS
TUESDAY, June 17, 2025 – Individuals with pediatric-onset multiple sclerosis (POMS) have greater epigenetic age and age acceleration residual (AAR) compared with age-similar controls, according to a...
Children With MS Age Faster, Study Says
MONDAY, June 16, 2025 — Kids with multiple sclerosis (MS) age at an accelerated rate as the disease causes advanced wear and tear on their bodies, a new study says. This accelerated aging extends i...
Home-Based Exercise, Coaching Improves Fitness in Neuromuscular Diseases
WEDNESDAY, June 4, 2025 – Combined personalized home-based aerobic exercise and coaching improves physical fitness for people with neuromuscular diseases, according to a study published online June...
AI Can Help Track MS Progression
MONDAY, May 19, 2025 — Artificial intelligence (AI) can help detect when a person’s multiple sclerosis (MS) has reached an advanced state, a new study says. A newly developed AI correctly judged with ...
Neuromodulation Methods Show Comparable Outcomes for Neurogenic Bladder in Women With MS
WEDNESDAY, May 7, 2025 – For female patients with multiple sclerosis (MS), transcutaneous posterior tibial nerve stimulation (TPTNS) and repetitive transcranial magnetic stimulation (rTMS) are...
Experimental Drug Can Slow MS Disability
WEDNESDAY, April 9, 2025 – An experimental drug can help patients with advanced multiple sclerosis (MS) delay the progressive disability that comes with their disorder, a new clinical trial...
AAN: Tolebrutinib Slows Disability in Nonrelapsing Secondary Progressive MS
WEDNESDAY, April 9, 2025 – Tolebrutinib, a brain-penetrant and bioactive Bruton tyrosine kinase inhibitor that modulates persistent immune activation within the central nervous system, slows...
Further information
Related drug support groups
prednisone, methylprednisolone, Medrol, prednisolone, valacyclovir, dexamethasone, Tecfidera, Ocrevus, Gilenya, dimethyl fumarate, Aubagio